Gabriel Marques dos Anjos

Universidade de São Paulo

Papers

1

Total Citations

23

H-Index

1

About

Dr. Gabriel Marques dos Anjos is a leading urologic oncologist whose research focuses on improving staging accuracy and surgical outcomes for prostate cancer patients. His most impactful work centers on the use of Ga68-PSMA PET imaging for lymph node staging in intermediate and high-risk prostate cancer, a field where he has made seminal contributions. In his highly cited 2024 paper (23 citations), Dr. dos Anjos demonstrated the superior sensitivity of Ga68-PSMA PET over conventional CT and MRI for detecting nodal metastases in patients undergoing robotic-assisted radical prostatectomy. This work has directly influenced preoperative staging protocols, enabling more precise surgical planning and reducing the risk of understaging. His research bridges the gap between advanced molecular imaging and robotic surgical techniques, helping to personalize treatment for men with aggressive disease. With a growing citation impact, Dr. dos Anjos is recognized for translating cutting-edge nuclear medicine into practical urologic oncology, ultimately improving the accuracy of lymph node assessment and guiding more effective, less invasive surgical interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy
23 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Universidade de São Paulo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago